Status:
COMPLETED
Prevention of Cardiac and Vascular Events in Patients With NGT/IGT.
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
30+ years
Phase:
PHASE3
Brief Summary
Impaired glucose tolerance or mild glucose elevations in the non-diabetic range are associated with increased cardiovascular disease and recent studies suggested the need to detect these glucose abnor...
Detailed Description
Condition: Patients submitted to coronary revascularization characterized for glucose tolerance after OGTT Intervention: L-arginine for 6 months Inclusion criteria: patients in stable clinical conditi...
Eligibility Criteria
Inclusion
- patients in stable clinical conditions after coronary revascularization (CABG and percutaneous angioplasty with/without stent implantation).
- Age \> 30 years, male and female.
- Fasting glucose levels below 126 mg/dl.
Exclusion
- Type 1 diabetes mellitus,
- known type 2 diabetes mellitus,
- pregnancy,
- impaired kidney and liver function,
- severe and not treated arterial hypertension.
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
End Date :
November 1 2006
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00408577
Start Date
November 1 2004
End Date
November 1 2006
Last Update
December 12 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scientific Institute San Raffaele
Milan, Milan, Italy, 20132